Literature DB >> 23463390

Variants in PTPN22 and SMOC2 genes and the risk of thyroid disease in the Jordanian Arab population.

Asem Alkhateeb1, Nour Al-Dain Marzouka, Reema Tashtoush.   

Abstract

Autoimmune thyroid diseases (AITDs) (Hashimoto thyroiditis and Graves' disease) are complex polygenic disorders with multiple genes thought to contribute to the risk of disease. The contribution of these genes differs by different populations. The PTPN22 gene is reported to be associated with multiple autoimmune diseases, but results of association are conflicting in different populations. The SMOC2 gene is reported to be associated with families with autoimmune vitiligo that had other autoimmunities including thyroid disease. The study aims to investigate the association of PTPN22 and SMOC2 single nucleotide polymorphisms with thyroid disease in a cohort of Jordanian patients. We collected blood samples from 204 thyroid patients and 216 normal controls. We used PCR-RFLP to genotype rs2476601 in PTPN22 and rs13208776 in SMOC2 genes. Both of the SNPS did not show significant association with thyroid disease, even after stratification according to subtype of disease (Hashimoto thyroiditis and Graves' disease) or gender. We reanalyzed SMOC2 SNP using a dominant and recessive models and we got marginal significance when using a dominant model with female-only patients (P = 0.052). PTPN22 SNP did not show association with autoimmune thyroid disease in our patient cohort. This may be due to the low frequency of this SNP in the Jordanian population. SMOC2 SNP, on the other hand, may play a role in AITD susceptibility as a dominant polymorphism. Additional samples might be needed to confirm or exclude association of SMOC2 with AITD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23463390     DOI: 10.1007/s12020-013-9908-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  35 in total

1.  The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity.

Authors:  Edward F Rocnik; Peijun Liu; Kaori Sato; Kenneth Walsh; Cyrus Vaziri
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

2.  Saturation multipoint linkage mapping of chromosome 6q in type 1 diabetes.

Authors:  J L Davies; F Cucca; J V Goy; Z A Atta; M E Merriman; A Wilson; A H Barnett; S C Bain; J A Todd
Journal:  Hum Mol Genet       Date:  1996-07       Impact factor: 6.150

3.  The developmentally-regulated Smoc2 gene is repressed by Aryl-hydrocarbon receptor (Ahr) signaling.

Authors:  Peijun Liu; Dorothy E Pazin; Rebeka R Merson; Kenneth H Albrecht; Cyrus Vaziri
Journal:  Gene       Date:  2008-12-24       Impact factor: 3.688

4.  Immunization with thyroglobulin induces Graves'-like disease in mice.

Authors:  Toyoshi Endo; Tetsuro Kobayashi
Journal:  J Endocrinol       Date:  2009-06-02       Impact factor: 4.286

5.  Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease.

Authors:  Thea G A Strieder; Mark F Prummel; Jan G P Tijssen; Eric Endert; Wilmar M Wiersinga
Journal:  Clin Endocrinol (Oxf)       Date:  2003-09       Impact factor: 3.478

6.  PTPN22 allele polymorphisms in 15 Chinese populations.

Authors:  Z-H Zhang; F Chen; X-L Zhang; Y Jin; J Bai; S-B Fu
Journal:  Int J Immunogenet       Date:  2008-12       Impact factor: 1.466

7.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

8.  Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27.

Authors:  D F Luo; M M Bui; A Muir; N K Maclaren; G Thomson; J X She
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

9.  New genetic insights from autoimmune thyroid disease.

Authors:  Terry F Davies; Rauf Latif; Xiaoming Yin
Journal:  J Thyroid Res       Date:  2012-02-28

10.  PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis.

Authors:  Michele Ciro Totaro; Barbara Tolusso; Valerio Napolioni; Francesca Faustini; Silvia Canestri; Alice Mannocci; Elisa Gremese; Silvia Laura Bosello; Stefano Alivernini; Gianfranco Ferraccioli
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

View more
  11 in total

1.  The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.

Authors:  Daniela Josabeth López-Cano; Daniel Cadena-Sandoval; Olga Beltrán-Ramírez; Rosa Elda Barbosa-Cobos; Fausto Sánchez-Muñoz; Luis Manuel Amezcua-Guerra; Yaneli Juárez-Vicuña; María Concepción Aguilera-Cartas; José Moreno; Jesús Bautista-Olvera; Guillermo Valencia-Pacheco; Ricardo F López-Villanueva; Julian Ramírez-Bello
Journal:  Inflamm Res       Date:  2017-05-12       Impact factor: 4.575

2.  Moderating Role of TSHR and PTPN22 Gene Polymorphisms in Effects of Excessive Fluoride on Thyroid: a School-Based Cross-Sectional Study.

Authors:  Yang Wang; Yushan Cui; Dandan Zhang; Chen Chen; Changchun Hou; Lichun Cao
Journal:  Biol Trace Elem Res       Date:  2021-05-28       Impact factor: 3.738

Review 3.  Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci.

Authors:  Changbing Shen; Jing Gao; Yujun Sheng; Jinfa Dou; Fusheng Zhou; Xiaodong Zheng; Randy Ko; Xianfa Tang; Caihong Zhu; Xianyong Yin; Liangdan Sun; Yong Cui; Xuejun Zhang
Journal:  Front Genet       Date:  2016-02-01       Impact factor: 4.599

4.  Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression.

Authors:  Jing-Ran Su; Jing-Hua Kuai; Yan-Qing Li
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

5.  The SPARC-related modular calcium binding protein 2 (SMOC2) gene polymorphism in primary glaucoma: a case-control study.

Authors:  Najwa Al-Dabbagh; Hamoud Al-Shahrani; Nourah Al-Dohayan; Md Mustafa; Misbahul Arfin; Abdulrahman K Al-Asmari
Journal:  Clin Ophthalmol       Date:  2017-03-20

Review 6.  Secreted modular calcium-binding proteins in pathophysiological processes and embryonic development.

Authors:  Qiang Gao; Hsiao-Pei Mok; Jian Zhuang
Journal:  Chin Med J (Engl)       Date:  2019-10-20       Impact factor: 2.628

7.  SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers.

Authors:  Bo Gun Jang; Hye Sung Kim; Jeong Mo Bae; Woo Ho Kim; Heung Up Kim; Gyeong Hoon Kang
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

Review 8.  Type 1 Diabetes and Autoimmune Thyroid Disease-The Genetic Link.

Authors:  Lara Frommer; George J Kahaly
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-10       Impact factor: 5.555

Review 9.  The association of PTPN22 rs2476601 polymorphism and CTLA-4 rs231775 polymorphism with LADA risks: a systematic review and meta-analysis.

Authors:  Fang Dong; Guang Yang; Hong-Wei Pan; Wei-Huang Huang; Li-Peng Jing; Wen-Kai Liang; Na Zhang; Bao-Huan Zhang; Man Wang; Yang Liu; Li-Ju Zhang; Si-Heng Zhang; He Li; Chuan Chen; Li-Hong Nie; Chun-Xia Jing
Journal:  Acta Diabetol       Date:  2014-07-09       Impact factor: 4.280

10.  Novel missense mutation in PTPN22 in a Chinese pedigree with Hashimoto's thyroiditis.

Authors:  Licheng Gong; Beihong Liu; Jing Wang; Hong Pan; Anhui Qi; Siyang Zhang; Jinyi Wu; Ping Yang; Binbin Wang
Journal:  BMC Endocr Disord       Date:  2018-11-01       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.